Generics bulletin is the global generic & biosimilar medicine industries essential source of news and views on product launches, company deals, regulatory changes and patent, pricing and reimbursement issues. Subscribers receive a weekly electronic newsflash and a twice-monthly magazine that ensures topical coverage and provides analysis from a generic & biosimilar industry perspective. Generics bulletin is available in print and digital versions.
The digital version, Generics bulletin-i also includes a fully-searchable archive containing over 100 back issues. For further information please visit www.generics-bulletin.com contact email@example.com or telephone +44 (0)1564 777550.